Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP891872.RAGp2Y2pltG9s64SFgSyoPpT7CUj47EqkPCmpOcg4eOQ4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP891872.RAGp2Y2pltG9s64SFgSyoPpT7CUj47EqkPCmpOcg4eOQ4130_assertion type Assertion NP891872.RAGp2Y2pltG9s64SFgSyoPpT7CUj47EqkPCmpOcg4eOQ4130_head.
- NP891872.RAGp2Y2pltG9s64SFgSyoPpT7CUj47EqkPCmpOcg4eOQ4130_assertion description "[Recently, a cirrhosis risk score (CRS) based on seven single-nucleotide polymorphisms was proposed as genetic predictor of cirrhosis in hepatitis C. To assess the role of CRS in predicting fibrosis progression in patients with initially no or minimal to moderate fibrosis, we investigated 271 untreated patients with chronic hepatitis C having initial liver biopsy showing METAVIR stage F0 (n = 104), F1 (n = 101), or F2 (n = 59) who had been followed up without antiviral therapies for at least 60 months (mean 108.5 +/- 71.5 months) and had a liver biopsy at the end of this observation period.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891872.RAGp2Y2pltG9s64SFgSyoPpT7CUj47EqkPCmpOcg4eOQ4130_provenance.
- NP891872.RAGp2Y2pltG9s64SFgSyoPpT7CUj47EqkPCmpOcg4eOQ4130_assertion evidence source_evidence_literature NP891872.RAGp2Y2pltG9s64SFgSyoPpT7CUj47EqkPCmpOcg4eOQ4130_provenance.
- NP891872.RAGp2Y2pltG9s64SFgSyoPpT7CUj47EqkPCmpOcg4eOQ4130_assertion SIO_000772 19676127 NP891872.RAGp2Y2pltG9s64SFgSyoPpT7CUj47EqkPCmpOcg4eOQ4130_provenance.
- NP891872.RAGp2Y2pltG9s64SFgSyoPpT7CUj47EqkPCmpOcg4eOQ4130_assertion wasDerivedFrom befree-20140225 NP891872.RAGp2Y2pltG9s64SFgSyoPpT7CUj47EqkPCmpOcg4eOQ4130_provenance.
- NP891872.RAGp2Y2pltG9s64SFgSyoPpT7CUj47EqkPCmpOcg4eOQ4130_assertion wasGeneratedBy ECO_0000203 NP891872.RAGp2Y2pltG9s64SFgSyoPpT7CUj47EqkPCmpOcg4eOQ4130_provenance.